Vulnerability Details : CVE-2018-14789

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3.1 or prior and Xcelera Version 4.1 or prior), an unquoted search path or element vulnerability has been identified, which may allow an attacker to execute arbitrary code and escalate their level of privileges.
Published 2018-08-22 18:29:00
Updated 2022-04-22 19:23:00
Source ICS-CERT
View at NVD,   CVE.org
Vulnerability category: Execute code

Exploit prediction scoring system (EPSS) score for CVE-2018-14789

EPSS FAQ
0.04%
Probability of exploitation activity in the next 30 days EPSS Score History
~ 8 %
Percentile, the proportion of vulnerabilities that are scored at or less

CVSS scores for CVE-2018-14789

Base Score Base Severity CVSS Vector Exploitability Score Impact Score Score Source First Seen
4.6
 MEDIUM AV:L/AC:L/Au:N/C:P/I:P/A:P
3.9
6.4
 NIST
6.7
 MEDIUM CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H
0.8
5.9
 NIST

CWE ids for CVE-2018-14789

  • The product uses a search path that contains an unquoted element, in which the element contains whitespace or other separators. This can cause the product to access resources in a parent path.
    Assigned by:
    • ics-cert@hq.dhs.gov (Secondary)
    • nvd@nist.gov (Primary)

References for CVE-2018-14789

Products affected by CVE-2018-14789

This web site uses cookies for managing your session, storing preferences, website analytics and additional purposes described in our privacy policy.
By using this web site you are agreeing to CVEdetails.com terms of use!
Accept Close